1. Contracts ending soon
  2. National Institutes of Health
  3. NAICS 541715

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) contracts ending at National Institutes of Health

Department of Health and Human Services

430 contracts of $100,000 or more under NAICS 541715, research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), at National Institutes of Health end in the next 18 months, with $4.44B obligated so far. 150 end within six months, so their follow-on may already be in the works.

Ending in 18 months
430 contracts$4.44B obligated so far
Biggest holder
Leidos Biomedical Research Inc$1.64B on 53 contracts ending soon
Open notices
NAICS 541715contract opportunities open now
Source
USAspending.govUpdated Nov 17, 2026, 7:37 PM UTC

Contracts ending soon

Soonest end first, the first 300. Each contract links to its record on USAspending.gov.

ContractObligatedEndsState
FY24 Facilities to C - 126610 B555 Chiller Vfd InstallLeidos Biomedical Research Inc · 75N91024F00019$813,345Nov 24, 2026within a monthMD
"core Nichd Network Clinical Site Support for Impaact Related Studies"Westat, Inc. · 75N94023F00002$13,095,838Nov 29, 2026within a monthMD
"support Services for the Hiv Aids Clinical Trial Networks"Westat, Inc. · 75N94023F00001$11,022,336Nov 29, 2026within a monthMD
Hispanic Community Health Study - Study of Latinos (Hchs-Sol) Coordinating Center - Task Area a - Core Study OperationsUniversity of North Carolina at Chapel Hill · 75N92025F00001$5,758,357Nov 29, 2026within a monthNC
Hispanic Community Health Study - Study of Latinos (Hchs-Sol) Bronx Field CenterAlbert Einstein College of Medicine · 75N92025F00001$4,140,211Nov 29, 2026within a monthNY
Hispanic Community Health Study - Study of Latinos (Hchs-Sol) Chicago Field Center - Task Area a - Core Study OperationsUniversity of Illinois · 75N92025F00001$3,378,983Nov 29, 2026within a monthIL
Hispanic Community Health Study - Study of Latinos (Hchs-Sol) Miami Field Center - Task Area a - Core Study OperationsUniversity of Miami · 75N92025F00001$3,317,452Nov 29, 2026within a monthFL
Hispanic Community Health Study - Study of Latinos (Hchs-Sol) San Diego Field Center - Task Area a - Core Study OperationsSan Diego State University Foundation · 75N92025F00001$3,070,153Nov 29, 2026within a monthCA
Research and Development Product Storage and ShippingDuke University · 75N93022F00001$2,889,750Nov 30, 2026within a monthNC
Research and Development Product Storage and ShippingMriglobal · 75N93022F00001$2,167,699Nov 30, 2026within a monthMO
Pk/Pd and Effect of T-5224 on Hiv-1 Transcriptional Activity in an Hiv-1-Mouse ModelBoard of Regents of the University of Nebraska · 75N93024F00001$1,207,737Nov 30, 2026within a monthNE
Virology Core LaboratoryDuke University · 75N93025C00002$1,876,865Dec 14, 2026within a monthNC
75N93021D00012/to 75N93024F00001 Fisher Bioservices Inc Preclinical Services for Hiv Therapeutics Daids-Car Base Award Can 8470035 $147,227.00Fisher Bioservices Inc · 75N93024F00001$441,422Dec 14, 2026within a monthMD
Multi-Ethnic Study of Atherosclerosis (Mesa) - Task Area aUniversity of Washington · 75N92025F00001$5,382,898Dec 18, 2026in 1 monthWA
Multi-Ethnic Study of Atherosclerosis (Mesa) - Field CenterNorthwestern University · 75N92025F00001$1,400,178Dec 18, 2026in 1 monthIL
Multi-Ethnic Study of Atherosclerosis (Mesa)Regents of the University of Minnesota · 75N92025F00001$1,317,759Dec 18, 2026in 1 monthMN
Multi-Ethnic Study of Atherosclerosis (Mesa) - Field Center (Fc), Task Area aUniversity of California, Los Angeles · 75N92025F00001$1,123,386Dec 18, 2026in 1 monthMD
Multi-Ethnic Study of Atherosclerosis (Mesa) - Field Center, Task Area aWake Forest University Health Sciences · 75N92025F00001$836,590Dec 18, 2026in 1 monthNC
Multi-Ethnic Study of Atherosclerosis (Mesa) - Field Center (Fc) - Task Area aThe Trustees of Columbia University in the City of New York · 75N92026F00001$437,119Dec 18, 2026in 1 monthMD
Conduct Study P223The Administrators of Tulane Educational Fund · 75N93024F00001$1,540,805Dec 24, 2026in 1 monthLA
NIH Odss Requires Assistance of Mitre in Order to Provide Support of an Ai Assurance Lab to Develop the Tools and Technology to Test Ai Systems, and More Appropriate Use in Biomedical & Health…The Mitre Corporation · 75N98024F00195$1,827,677Dec 25, 2026in 1 monthVA
Task Order B-1, Animal Model Development and Efficacy Testing of Candidate McmsSri International · 75N93020F00002$14,486,445Dec 30, 2026in 1 monthCA
Development of an Intranasal Vaccine Against Gonorrhea Based on Outer Membrane Vesicles Combined With Sustained-Release Microspheres Containing Recombinant Human Interleukin-12.Intravacc B.v. · 75N93022C00058$6,612,767Dec 30, 2026in 1 monthNot stated
Screening of Investigational Therapeutics to Treat, Modify or Prevent Epilepsy for the Ninds Epilepsy Therapy Screening Program (Etsp)University of Utah · 75N95022C00007$26,486,841Dec 31, 2026in 1 monthUT
To Conduct a Phase 2 Dengue Human Challenge Clinical Trial of Abviro Anti-Dengue Monoclonal Antibody (Mab) Av-1.Abviro LLC · 75N93023C00055$11,335,102Dec 31, 2026in 1 monthMD
To Conduct Clinical Development of a Compound for the Treatment of Covid-19.Aligos Therapeutics Inc · 75N93023C00052$11,286,393Dec 31, 2026in 1 monthCA
Baa Research Area 004: Development of in Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections (Amr), and Emerging Infectious Diseases.Siemens Healthcare Diagnostics Inc. · 75N93023C00025$5,422,657Dec 31, 2026in 1 monthNY
To Conduct Non-Clinical Good Laboratory Practice (Glp) in Vivo Genotoxicity and Reproductive Toxicology and Glp Development and Reproductive (Dart) Toxicology Studies.Arisan Therapeutics Inc · 75N93023C00051$3,692,037Dec 31, 2026in 1 monthCA
Reds-IV-P Brazil HubVitalant · 75N92024F00001$2,702,179Dec 31, 2026in 1 monthAZ
BAA2023-1 Research Area 004: Development of in Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections (Amr), and Emerging Infectious DiseasesClear Labs Inc · 75N93024C00052$2,443,961Dec 31, 2026in 1 monthCA
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Trained Human Sensory PanelsAdvanced Bioscience Laboratories, Inc. · 75N93024F00002$2,413,956Dec 31, 2026in 1 monthMD
Reds-IV-P Center for Transfusion Laboratory StudiesVitalant · 75N92024F00001$2,160,438Dec 31, 2026in 1 monthAZ
Reds-IV-P Domestic HubsVitalant · 75N92024F00001$2,104,121Dec 31, 2026in 1 monthAZ
Reds-IV-P Domestic HubsVersiti Blood Health, Inc. · 75N92024F00001$1,656,613Dec 31, 2026in 1 monthWI
Risk Underlying Rural Areas Longitudinal (Rural) Heart and Lung Study, Task Area B.1 - Completion of Baseline Examination (Exam 1): 4/22/2026 - 12/31/2026The University of Texas Health Science Center at San Antonio · 75N98026F00002$1,595,622Dec 31, 2026in 1 monthTX
Clinical Trial Materials for Virus VaccinesCharles River Laboratories, Inc. · 75N93023F00002$374,769Dec 31, 2026in 1 monthMA
Clinical Trial Materials for Virus VaccinesCharles River Laboratories, Inc. · 75N93023F00003$296,136Dec 31, 2026in 1 monthMA
Ncat:Service:Tex-Val Tissue Chip Testing (Tex-Val) Consortium Membership 2026:SeverableTexas A & M University · 75N98026P00641$100,000Dec 31, 2026in 1 monthTX
Base Award for Using Rodent Behavioral Models to Identify Substance Abuse PharmacotherapiesThe University of North Texas Health Science Center at Fort Worth · 75N95023C00002$3,600,396Jan 3, 2027in 1 monthTX
Task Order 75N93022F00001 Base AwardDynport Vaccine Company LLC · 75N93022F00001$1,028,570Jan 13, 2027in 1 monthMD
Task Order 75N93022F00001 Base AwardDuke University · 75N93022F00001$959,533Jan 13, 2027in 1 monthNC
Task Order 75N93022F00001 Base AwardPpd Development Lp · 75N93022F00001$905,501Jan 13, 2027in 1 monthNC
Task Order 75N93022F00001 Base AwardIcon Government and Public Health Solutions, Inc. · 75N93022F00001$803,929Jan 13, 2027in 1 monthOH
Task Order 75N93022F00001 Base AwardAllucent Government Services (US) LLC · 75N93022F00001$698,645Jan 13, 2027in 1 monthTX
FY24 Sbir Phase II Rd Contract - Topic 442 Boston Cell Standards, Inc.Boston Cell Standards Inc. · 75N91024C00087$1,995,119Jan 15, 2027in 1 monthMA
Wedgewood Expansion Design Suites M & NLeidos Biomedical Research Inc · 75N91021F00019$7,763,273Jan 26, 2027in 2 monthsMD
FY25 to-C Refurbish ElevatorsLeidos Biomedical Research Inc · 75N91025F00008$10,123,627Jan 27, 2027in 2 monthsMD
FY24 Facilities to J Atrf Bdp Facility ImprovementsLeidos Biomedical Research Inc · 75N91024F00031$413,982Jan 27, 2027in 2 monthsMD
To Advance a Promising, Small-Molecule Compound CRS0540 to Ind Filing and Through Phase I Clinical Studies.Crestone, Inc. · 75N93020C00020$22,028,937Jan 31, 2027in 2 monthsCO
On Behalf of Dcr Facilitate the Conduct of an Observational Study to Characterize Patients With Covid-19 Infection (10,000 Subjects).Leidos Biomedical Research Inc · 75N91020F00008$18,109,529Jan 31, 2027in 2 monthsMD
Women's Health Initiative (Whi) Clinical Coordinating Center - Task Area a and A2Fred Hutchinson Cancer Center · 75N92026F00001$10,225,386Jan 31, 2027in 2 monthsWA
Office-Based Methadone Vs Buprenorphine to Address Retention in Medication for Opioid Use Disorder (Moud)-a Pragmatic Hybrid Effectiveness/Implementation Trial (Ctn-013). 09/28/2022 - 08/04/2025…The Emmes Company, LLC · 75N95022F00003$1,861,518Jan 31, 2027in 2 monthsMD
Coronary Artery Risk Development in Young Adults (Cardia) Study - Coordinating Center (Cc)University of Alabama at Birmingham · 75N92026F00001$1,251,091Jan 31, 2027in 2 monthsAL
Standard and High Dose Ed Buprenorphine Induction. 09/15/2023 - 05/31/2026. N01DA-22-2253. Task Order 75N95023F00005 (TO9).The Emmes Company, LLC · 75N95023F00005$1,249,376Jan 31, 2027in 2 monthsMD
Coronary Artery Risk Development in Young Adults (Cardia) Study - Oakland Field CenterKaiser Foundation Hospitals · 75N92026F00001$1,091,868Jan 31, 2027in 2 monthsCA
Better Together: Integrating Moud in African American Community Settings. September 15, 2023 to January 31, 2026. N01DA-22-2253. Task Order 75N95023F00004 (TO8).The Emmes Company, LLC · 75N95023F00004$999,995Jan 31, 2027in 2 monthsMD
Coronary Artery Risk Development in Young Adults (Cardia) Study - Chicago Field CenterNorthwestern University · 75N92026F00001$842,381Jan 31, 2027in 2 monthsIL
Pharmacokinetics of Long-Acting Preparations of Antitubercular Drugs in RodentsSri International · 75N93025F00001$830,604Jan 31, 2027in 2 monthsCA
Coronary Artery Risk Development in Young Adults (Cardia) Study - University of Minnesota Field Center.Regents of the University of Minnesota · 75N92026F00001$780,454Jan 31, 2027in 2 monthsMN
This Is a Cpff to to Refurbish Apa Buildings 1034Leidos Biomedical Research Inc · 75N91022F00031$6,274,892Feb 5, 2027in 2 monthsMD
This Is a Cpff to to Refurbish Apa Buildings (1033).Leidos Biomedical Research Inc · 75N91022F00030$6,232,704Feb 5, 2027in 2 monthsMD
FY22 - Apa Buildings - Building 2Leidos Biomedical Research Inc · 75N91022F00028$6,180,966Feb 5, 2027in 2 monthsMD
FY22 - Apa Buildings - Building 1Leidos Biomedical Research Inc · 75N91022F00027$5,729,256Feb 5, 2027in 2 monthsMD
Framingham Heart Study (Fhs), Task Area a - Core Study OperationsTrustees of Boston University · 75N92025F00001$13,694,236Feb 13, 2027in 2 monthsMD
Strong Heart Study (Shs)- Coordinating Center (Cc)- Task Order 001University of Oklahoma · 75N92019F00074$14,413,239Feb 14, 2027in 2 monthsOK
Strong Heart Study (Shs)- Field Center, Task Order 001Missouri Breaks Industries Research, Inc · 75N92019F00074$5,720,691Feb 14, 2027in 2 monthsSD
Strong Heart Study (Shs)- Field Center (Fc)- Task Order 001University of Oklahoma · 75N92019F00074$5,273,991Feb 14, 2027in 2 monthsOK
Strong Heart Study (Shs) - Field Center, Task Order 001, Base Period, February 15, 2019 to February 14, 2020Medstar Health Research Institute Inc. · 75N92019F00074$3,592,276Feb 14, 2027in 2 monthsMD
The Goal of This Task Order Is to Perform Pharmacoepidemiology Research and a Pk, Pharmacodynamic, Pharmacogenomic, Efficiency, and Safety Trial of the Highest Recommended Dose of Sildenafil in…Duke University · 75N94022F00001$1,457,295Feb 14, 2027in 2 monthsNC
Health Effects and Dosimetry in a Cohort of Persons Exposed in Utero and in a Cohort of Women Exposed During Lactation to Chernobyl Fallout.Gu Rnpts Rmiech · 75N91024F00002$481,709Feb 14, 2027in 2 monthsNot stated
Strong Heart Study (Shs) - University of Oklahoma, Field Center (Fc), Task Area C: Data BookUniversity of Oklahoma · 75N92026F00001$469,049Feb 14, 2027in 2 monthsMD
Strong Heart Study (Shs) - Missouri Breaks Industries Research, Inc., Field Center (Fc), Task Area C: Data BookMissouri Breaks Industries Research, Inc · 75N92026F00001$154,846Feb 14, 2027in 2 monthsMD
Strong Heart Study (Shs) - Medstar Health Research Institute, Inc., Field Center (Fc), Task Area C: Data BookMedstar Health Research Institute Inc. · 75N92026F00001$129,024Feb 14, 2027in 2 monthsMD
Cohorts Maintenance and LinkageGu Rnpts Rmiech · 75N91024F00001$183,391Feb 15, 2027in 2 monthsNot stated
Preclinical Medications Discovery and Abuse Liability Testing for Nida Nida Ref. No. N01DA-22-8959. Base Award.Virginia Commonwealth University · 75N95022C00004$4,781,242Feb 21, 2027in 3 monthsVA
Clinical Verification and Validation of a Wearable Near-Infrared Blood Alcohol Content Monitor.Vivonics Inc · 75N94023C00012$2,049,833Feb 21, 2027in 3 monthsMA
Nci-Dcp-21-0103 Coordinating Center for the Nci Cervical Cancer Last Mile Initiative Self-Sampling for Hpv Testing to Improve Cervical Cancer Prevention Ship TrialLeidos Biomedical Research Inc · 75N91021F00014$7,985,184Feb 26, 2027in 3 monthsMD
Niaid Covid-19 ACTIV3Leidos Biomedical Research Inc · 75N91020F00039$159,121,570Feb 28, 2027in 3 monthsMD
To Develop a Novel Modulator Targeting Proteostasis for the Treatment of M. Tuberculosis.The Global Alliance for Tb Drug Development Inc · 75N93024C00008$2,475,623Feb 28, 2027in 3 monthsNY
Dsc Management and Support. April 29, 2026 Through February 28, 2027. N01DA-22-2253. Task Order No. 75N98026F00002 (to 28)The Emmes Company, LLC · 75N98026F00002$2,359,700Feb 28, 2027in 3 monthsMD
Maintenance of the Nhlbi Biologic Specimen Repository Task Area B and Task Area CPrecision for Medicine, Inc. · 75N98026F00001$1,297,259Feb 28, 2027in 3 monthsMD
Rapid Rt-Lamp Assay for Self-Monitoring of Acute or Rebound Hiv-1 Infection Using Finger-Prick Whole Blood Sample and Rna ExtractionAi Biosciences, Inc. · 75N93025C00027$300,000Feb 28, 2027in 3 monthsTX
Development of a Rapid, Quantitative Hiv-1 Assay for Viral Load Self-MonitoringBaebies, Inc. · 75N93025C00028$299,427Feb 28, 2027in 3 monthsNC
Iitri - Performance Area 1 TO2Iit Research Institute · 75N95024F00001$212,495Feb 28, 2027in 3 monthsIL
Sbir Phase II, Topic 431: Automatic Treatment Planning of Cervical Cancer High-Dose Rate Brachytherpay for Low-Resource Settings.Veloxai LLC · 75N91024C00073$2,000,000Mar 3, 2027in 3 monthsTX
Novel Mucosal Vaccine Approaches for Pneumonia.The Administrators of Tulane Educational Fund · 75N93022C00056$6,592,393Mar 6, 2027in 3 monthsLA
Phase I Single Ascending Dose Study. TO7. Nida Pharmacokinetic Analysis Resource Center. 09/10/2024 - 03/09/2026. Nida Ref. No. N01DA-19-8947.Technical Resources International, Inc. · 75N95024F00001$415,717Mar 8, 2027in 3 monthsMD
Investigational Agent Single Ascending Dose Safety, Tolerability, and Pk Study. September 3, 2024 to March 2, 2026. N01DA-23-8935Altasciences Clinical Kansas Inc · 75N95024F00001$1,724,199Mar 10, 2027in 3 monthsKS
Nhlbi Biologic Specimen RepositoryPrecision for Medicine, Inc. · 75N92024F00001$5,115,700Mar 13, 2027in 3 monthsMD
Development and Maintenance of an Aged Rodent Tissue Bank Period of Performance: 3/15/2021 - 3/14/2022University of Washington · 75N95021C00008$1,677,187Mar 14, 2027in 3 monthsWA
Task Order No. 0001 - Medicinal Chemistry Support Program for Therapeutic Development (McspCuria Global Inc · HHSN27100001$173,705Mar 15, 2027in 3 monthsNY
Research Triangle Institute:1109097 [26-001544]Research Triangle Institute · 75N98026F00002$907,528Mar 19, 2027in 4 monthsMD
Task Order 1 - Ocr Project Management, Dsmb and Croms-Related SupportDigital Infuzion, LLC · 75N95024F00001$14,674,827Mar 24, 2027in 4 monthsMD
Nichd: R&D: Metabolome of Sleep and Adverse Birth Outcomes: Non-SeverableRegents of the University of Minnesota · 75N94025F00002$916,859Mar 25, 2027in 4 monthsMN
Animal Care and Laboratory Support Services to the Vaccine Research CenterBioqual, Inc. · 75N93019C00069$64,445,753Mar 27, 2027in 4 monthsMD
The Purpose of This Task Order Is to (a) Acquiring, Procuring and/or Manufacturing Materials Required for the Generation of a Scalable in Vitro Transcription (Ivt) Reaction, the Purification of the…Duke University · 75N93023F00001$6,769,527Mar 28, 2027in 4 monthsNC
Characterization of MpoxLeidos Biomedical Research Inc · 75N91025F00017$5,583,900Mar 28, 2027in 4 monthsMD
Nonhuman Primate Core Humoral Immunology Laboratory for Aids Vaccine Research and DevelopmentDuke University · 75N93025C00006$5,120,519Mar 29, 2027in 4 monthsNC
Clinical Research Operations and Management Support (Croms)Technical Resources International, Inc. · 75N93024C00004$72,737,128Mar 31, 2027in 4 monthsMD
To Maintain and Operate Secure State-of-the-Art Computer-Based Systems That Provide for Tracking, Processing, Coordination, and Analysis of Data Collected, Generated, and Processed Primarily by the…Digital Infuzion, LLC · 75N93021C00007$18,812,223Mar 31, 2027in 4 monthsMD
Task Order 75N93020D00008/75N93020F00004: Operation of a Nonhuman Primate Breeding ColonyUniversity of Louisiana at Lafayette · 75N93020F00004$13,444,350Mar 31, 2027in 4 monthsLA
To Advance the Development of the Shigetec Vaccine Through Cgmp Manufacturing and Release of Additional Cgmp Lots for Use in a Series of Phase 2 Clinical Trials.Eveliqure Biotechnologies Gmbh · 75N93020C00048$11,480,630Mar 31, 2027in 4 monthsNot stated
Data Systems Update, Data Integration, and Computational Applications to Support Drug Discovery and Therapeutics DevelopmentLeidos Biomedical Research Inc · 75N91020F00015$8,410,146Mar 31, 2027in 4 monthsMD
National Addiction and Hiv Data Archive Program.Regents of the University of Michigan · 75N95024C00005$4,713,075Mar 31, 2027in 4 monthsMI
Niaid Clinical Products Center (Cpc)Eminent Services Corp · 75N93026C00003$3,634,911Mar 31, 2027in 4 monthsMD
Preclinical Toxicology of Large Molecule Drugs Developed for Cancer and Other IndicationsIit Research Institute · 75N91022C00010$3,452,984Mar 31, 2027in 4 monthsIL
Development of Second-Generation Probiotics As Radiation MitigatorsChromologic LLC · 75N93021C00008$2,709,458Mar 31, 2027in 4 monthsCA
Task Order 75N93020D00006/75N93020F00001: Core Activities: Administrative and Technical SupportBioqual, Inc. · 75N93020F00001$2,634,728Mar 31, 2027in 4 monthsMD
Ketamine for Methamphetamine Use Disorder Study (Ctn-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).The Emmes Company, LLC · 75N95022F00004$2,075,621Mar 31, 2027in 4 monthsMD
Task Order 75N93020D00008/75N93020F00001: Core Activities: Administrative and Technical SupportUniversity of Louisiana at Lafayette · 75N93020F00001$1,916,543Mar 31, 2027in 4 monthsLA
Task Order 75N93020D00007/75N93020F00001: Core Activities: Administrative and Technical SupportThe Administrators of Tulane Educational Fund · 75N93020F00001$1,798,743Mar 31, 2027in 4 monthsLA
Task Order 75N93020D00007/75N93020F00002: Maintenance of Nonhuman Primates in an ABSL2/3 FacilityThe Administrators of Tulane Educational Fund · 75N93020F00002$1,427,640Mar 31, 2027in 4 monthsLA
Task Order 75N93020D00006/75N93020F00002: Maintenance of Nonhuman Primates in an ABSL2/3 FacilityBioqual, Inc. · 75N93020F00002$1,350,312Mar 31, 2027in 4 monthsMD
Task Order 75N93020D00006/75N93020F00002: Maintenance of Nonhuman Primates in an ABSL2/3 FacilityUniversity of Louisiana at Lafayette · 75N93020F00002$941,815Mar 31, 2027in 4 monthsLA
Task Order 75N93020D00008/75N93020F00003: Maintenance of Nonhuman Primates in an ABSL2 FacilityUniversity of Louisiana at Lafayette · 75N93020F00003$886,417Mar 31, 2027in 4 monthsLA
Clinical Coordination, Monitoring and Evaluation of the Aids Clinical Trials Group Protocol A5418 Study of Tecovirimat for Human Monkeypox Virus (Stomp)Westat, Inc. · 75N94022F00004$605,168Mar 31, 2027in 4 monthsMD
Framingham Heart Study (Fhs), Task Area B - Protocol Development and Basic Examination, Year 2Trustees of Boston University · 75N98026F00001$2,433,276Apr 2, 2027in 4 monthsMD
The Purpose of This Contract to Support the Activities Required to Produce, Procure, Store, Ship, and Maintain High-Quality Reagents, Assays and or Services in Support of Preclinical and Clinical…Quality Biological Inc · 75N93025C00011$4,780,359Apr 7, 2027in 4 monthsMD
Conduct Study 222The Administrators of Tulane Educational Fund · 75N93024F00002$1,722,748Apr 11, 2027in 4 monthsLA
Quality Assurance/Quality Control (Qa/Qc) SupportAdvanced Bioscience Laboratories, Inc. · 75N93023F00001$2,171,969Apr 14, 2027in 4 monthsMD
Risk Underlying Rural Areas Longitudinal (Rural) Heart and Lung Study, Task Area a - Core Study Operations (Base Year: 4/22/2026 - 4/21/2027)The University of Texas Health Science Center at San Antonio · 75N98026F00001$4,247,461Apr 21, 2027in 5 monthsTX
Risk Underlying Rural Areas Longitudinal (Rural) Heart and Lung Study, Task Area B.2 - Protocol Development and Exam Conduct for Limited Examination (Exam 2): 4/22/2026 - 4/21/2027The University of Texas Health Science Center at San Antonio · 75N98026F00003$3,567,105Apr 21, 2027in 5 monthsTX
FY232 Facilities to G-B1073 Mold RemediationLeidos Biomedical Research Inc · 75N91023F00014$4,955,434Apr 27, 2027in 5 monthsMD
Clinical Trials Monitoring ServiceTheradex Systems, Inc. · 75N91022C00013$44,093,195Apr 30, 2027in 5 monthsNJ
Novation From Cpic to Ucsf Effect. 8/01/18 Surveillance, Epidemiology, and End Results (Seer) Program, Pop: 05/01/2018-04/30/2028Regents of the University of California, San Francisco, the · 75N91018F00001$41,535,322Apr 30, 2027in 5 monthsCA
Core Infrastructure Support for Surveillance, Epidemiology, and End Results (Seer)Fred Hutchinson Cancer Center · 75N91018F00001$39,002,751Apr 30, 2027in 5 monthsWA
Core InfrastructureUniversity of Southern California · 75N91018F00001$37,029,280Apr 30, 2027in 5 monthsCA
Seer - Core InfrastructurePublic Health Institute · 75N91018F00001$36,932,234Apr 30, 2027in 5 monthsCA
Surveillance, Epidemiology, and End Results (Seer) ProgramThe University of Iowa · 75N91018F00001$36,201,158Apr 30, 2027in 5 monthsIA
EO14042 Development, Statistical Design, Monitoring and Coordination of Vision Clinical Trials and Epidemiology ResearchThe Emmes Company, LLC · 75N98022C00001$32,539,945Apr 30, 2027in 5 monthsMD
Surveillance, Epidemiology, and End Results (Seer) ProgramDepartment of Public Health Connecticut · 75N91018F00001$28,525,485Apr 30, 2027in 5 monthsCT
Seer - Core InfrastructureEmory University · 75N91018F00001$26,349,170Apr 30, 2027in 5 monthsGA
Core Infrastructure Support for Surveillance, Epidemiology, and End Results (Seer)University of Kentucky Research Foundation, the · 75N91018F00001$25,506,724Apr 30, 2027in 5 monthsKY
Core Infrastructure Support for Surveillance, Epidemiology, and End Results (Seer) ProgramUniversity of New Mexico · 75N91018F00001$25,203,711Apr 30, 2027in 5 monthsNM
Seer - Core InfrastructureUniversity of Utah · 75N91018F00002$18,974,813Apr 30, 2027in 5 monthsUT
Core Infrastructure Support for Surveillance, Epidemiology, and End Results (Seer) - University of Hawaii Pop 5/1/18-4/30/19University of Hawaii · 75N91018F00001$14,454,998Apr 30, 2027in 5 monthsHI
Core Infrastructure Support for Surveillance, Epidemiology, and End Results (Seer) - Health Research Institute- Nys Doh Pop 5/1/18-4/30/19Health Research, Inc. · 75N91018F00001$13,894,843Apr 30, 2027in 5 monthsNY
Seer Core Infrastructure SupportDepartment of Public Health Illinois · 75N91021F00001$10,559,097Apr 30, 2027in 5 monthsIL
Decorporation Mcm Phase 1 Clinical Safety StudySri International · 75N93021F00001$9,754,263Apr 30, 2027in 5 monthsCA
Seer Core Infrastructure Support, Base PeriodRutgers the State University of New Jersey · 75N91021F00001$7,526,901Apr 30, 2027in 5 monthsNJ
Seer Core Infrastructure SupportDepartment of State Health Services · 75N91021F00001$6,273,513Apr 30, 2027in 5 monthsTX
Advanced Development of a Vaccine Candidate for Staphylococcus Aureus Infection and Colonization.Immunartes, LLC · 75N93022C00057$5,363,612Apr 30, 2027in 5 monthsIL
Core InfrastructureIdaho Hospital Association Inc · 75N91018F00001$4,897,859Apr 30, 2027in 5 monthsID
To Develop and Clinically Validate an Innovative Cell-Free Deoxyribonucleic Acid (Cfdna) Based Panel for Detecting Disease-Causing Fungi Directly From Plasma.Zepto Life Technology, Inc. · 75N93026C00010$1,878,981Apr 30, 2027in 5 monthsMN
Sudden Death in the Young Case Registry (Sdy) - Data Coordinating Center Biospecimen and Consent ActivitiesMichigan Public Health Institute · 75N92024C00001$1,435,334Apr 30, 2027in 5 monthsMI
Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells (Bhipsc-Lung). Ipsc Task Area B - Scientific ProjectsTrustees of Boston University · 75N92025F00002$1,140,920May 1, 2027in 5 monthsMA
Biorepository of Lung Disease-Specific Human Induced Pluripotent Stem Cells (Bhipsc-Lung). Bhipsc-Lung Task Area a Core Administrative TasksTrustees of Boston University · 75N92025F00001$267,133May 1, 2027in 5 monthsMA
NIH Odss Advancing Data Transparency Best Practices to Promote Scientific Reproducibility and RigorThe Mitre Corporation · 75N98026F00118$1,681,163May 6, 2027in 5 monthsVA
Functional Omics Core LaboratoryEmory University · 75N93025C00014$4,192,264May 14, 2027in 5 monthsGA
Task Order 75N93024F00001 Base Award.Allucent Government Services (US) LLC · 75N93024F00001$3,205,231May 14, 2027in 5 monthsNC
FY25 to-H W3F1 RenovationsLeidos Biomedical Research Inc · 75N91025F00026$1,856,809May 18, 2027in 6 monthsMD
Development of Target Characterization Methods for Novel Cancer MarkersLeidos Biomedical Research Inc · 75N91020F00026$56,499,671May 25, 2027in 6 monthsMD
The Purpose of This Task Order Is to Maintain and Enhance the Niddk Biorepository Routine Operations to Facilitate Biospecimen Utilization for New Science and Broad Sharing Across the Research…Precision for Medicine, Inc. · 75N94023F00001$16,371,498May 29, 2027in 6 monthsMD
Scientific Information Management and Literature-Based Evaluations for the National Toxicology Program (Ntp)Icf Incorporated, L.l.c. · 75N96025C00003$13,283,134May 29, 2027in 6 monthsVA
The Contractor Shall Provide Comprehensive Quality Assessment Programs to Clinical Pharmacology Laboratories (Labs) That Test Samples From Subjects Enrolled in Niaid Supported Clinical Studies…The Research Foundation for the State University of New York · 75N93022C00009$9,981,845May 29, 2027in 6 monthsNY
Cellular Immunology Core LaboratoryThe Administrators of Tulane Educational Fund · 75N93024C00007$8,047,879May 31, 2027in 6 monthsLA
High Throughput Genotyping and Dna Sequencing for Studying the Genetic Contributions to Human Health and Disease - Program ManagementThe Johns Hopkins University · 75N92024F00001$8,027,238May 31, 2027in 6 monthsMD
Support Services for Hiv Aids Clinical Trial NetworksWestat, Inc. · 75N94023F00001$7,991,085May 31, 2027in 6 monthsMD
To Carry Out Development for a Drug Candidate Small Molecule Inhibitor Against Chikungunya Virus, an Alphavirus That Causes Debilitating and Sometimes Life-Threatening Disease in Humans.Oregon Health & Science University · 75N93023C00002$7,422,654May 31, 2027in 6 monthsOR
HHSN275201800008I - New Task Order Phase 2: Recruitment and Follow-Up Study of Pregnancy and Neonatal Health (Span) (Aims 1 and 2) - Duke University - Can 8050079Duke University · 75N94024F00002$1,062,684May 31, 2027in 6 monthsNC
New Task Order Alcohol Cue Human Laboratory Study Testing Apremilast. Contractor to Serve As a Clinical Research Site for a Multiple-Site Clinical Trial to Test Apremilast for the Treatment of…The Regents of the University of Colorado · 75N94025F00002$665,788May 31, 2027in 6 monthsCO
New Task Order Award Alcohol Cue Human Laboratory Study Testing Apremilast. Contractor to Serve As a Clinical Research Site for a Multiple-Site Clinical Trial to Test Apremilast for the Treatment…University of California, Los Angeles · 75N94025F00002$579,102May 31, 2027in 6 monthsCA
Phase I Sbir Concept Award for Logic Gated Molecular Adaptor System for Jmml TreatmentGencyte Therapeutics Inc · 75N91025C00046$499,990May 31, 2027in 6 monthsCA
Nichd: R&D: Preclinical Safety and Toxicology Studies for Regulatory Requirements: Non-SeverableSri International · 75N94025F00002$1,497,846Jun 1, 2027in 6 monthsCA
Nichd: R&D: Essential Studies and Manufacture for Current Products in Ongoing Clinical Development: Non-SeverableSri International · 75N94025F00001$1,249,426Jun 1, 2027in 6 monthsCA
Nichd: R&D: Nonclinical Development of Contraceptive Products for Men and/or Women the Objective of This Task Order Is to Obtain Services for the Nonclinical Development of Contraceptive Products…Sri International · 75N94025F00004$684,493Jun 1, 2027in 6 monthsCA
Nichd: R&D: Best Pharmaceuticals for Children Act (Bpca) Pediatric Trials Network (Ptn): Core Function Activities - the Contractor Shall Establish and Maintain Centralized Teams of Experts Who Will…Duke University · 75N94025F00001$4,790,048Jun 3, 2027in 6 monthsNC
Synthesis and Distribution of Drugs of Abuse and Related Compounds. June 9, 2024 - June 8, 2025. Task Order 75N95024F00001 (TO6). N01DA-22-8944.Research Triangle Institute · 75N95024F00001$2,800,866Jun 8, 2027in 6 monthsNC
Eo: Radical Transparency About Wasteful Spending. Synthesis and Distribution of Drugs of Abuse and Related Compounds. June 9, 2025 - June 8, 2026. Task Order 75N95025F00001 (TO8). N01DA-22-8944.Research Triangle Institute · 75N95025F00001$1,960,606Jun 8, 2027in 6 monthsNC
Topic Number 431 Cancer Treatment Technologies for Low-Resource SettingsSpatial Surgical LLC · 75N91024C00098$1,987,032Jun 11, 2027in 6 monthsMA
Fg-2101: a First-in-Class Lpxc Inhibitor for the Treatment of Mdr Gramnegative Urinary Tract Infections.Blacksmith Medicines, Inc. · 75N93022C00060$14,562,694Jun 13, 2027in 6 monthsCA
Quantification of Drugs of Abuse and Related Substances in Biological Specimens. Period of Performance: June 14, 2024 - June 13, 2025.University of Utah · 75N95024C00014$782,637Jun 13, 2027in 6 monthsUT
Clinical Trial Materials for Virus Vaccines. Clinical Trial Material for Human Metapneumovirus (Hmpv) Pediatric Respiratory Virus Vaccine Lot Hmpv LOT#104. Task Order 13.Charles River Laboratories, Inc. · 75N98026F00002$339,743Jun 14, 2027in 6 monthsMA
Clinical Trial Materials for Virus Vaccines. Clinical Trial Material for Human Metapneumovirus (Hmpv) Pediatric Respiratory Virus Vaccine Lot Hmpv LOT#103. Task Order 12.Charles River Laboratories, Inc. · 75N98026F00001$339,743Jun 14, 2027in 6 monthsMA
Clinical Research Products Development Center (Crpmc)Fisher Bioservices Inc · 75N93020C00032$62,984,999Jun 15, 2027in 6 monthsMD
Synthesis and Distribution of Drugs of Abuse and Related Compounds. July 16, 2026 - June 15, 2027. Task Order 75N98026F00002 (TO11). N01DA-22-8944. Dap-Ncap-00000154Research Triangle Institute · 75N98026F00002$344,756Jun 15, 2027in 6 monthsNC
Subpopulations and Intermediate Outcomes in Copd (Spiromics) III - Spiromics - Task Area BRegents of the University of California, San Francisco, the · 75N92025F00002$584,533Jun 17, 2027in 7 monthsCA
BAA2023-1 Research Area 004: Development of in Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections (Amr), and Emerging Infectious DiseasesGe Medical Systems Information Technologies, Inc. · 75N93024C00051$6,685,998Jun 18, 2027in 7 monthsNY
Virology Quality Assurance (Vqa)Duke University · 75N93026C00005$3,408,692Jun 20, 2027in 7 monthsNC
Health Ffrdc Small Business Education and Entrepreneurial Development (Seed) Office Support for the National Institutes of Health (NIH), Office of the Director (Od), Oer, SeedThe Mitre Corporation · 75N94025F00041$1,999,992Jun 20, 2027in 7 monthsMD
FY23 Facilities to-aLeidos Biomedical Research Inc · 75N91023F00005$11,826,515Jun 24, 2027in 7 monthsMD
To Develop an Integrated Diagnostic Platform That Utilizes Whole Genome Sequencing (Wgs) to Identify Bacterial Pathogens and Predict Antibiotic Susceptibility Directly From Blood, Within a Few Hours…Genomic Labs Ltd · 75N93025C00025$3,439,742Jun 27, 2027in 7 monthsNot stated
National Institute of Allergy and Infectious Diseases (Niaid) Clinical Site Monitoring Center (Csmc)Ppd Development Lp · 75N93022C00014$36,391,559Jun 29, 2027in 7 monthsNC
Purpose: to Provide Clinical Trials Sponsor and Regulatory Management Support Services to the Nci, the Center for Cancer Research (Ccr), and Ccr Investigators.Technical Resources International, Inc. · 75N91021C00013$71,253,101Jun 30, 2027in 7 monthsMD
Drug Development Support for CtepTechnical Resources International, Inc. · 75N91022C00014$39,320,905Jun 30, 2027in 7 monthsMD
Division of Microbiology and Infectious Diseases: Regulatory Affairs SupportTechnical Resources International, Inc. · 75N93022C00010$18,038,206Jun 30, 2027in 7 monthsMD
Coronary Artery Risk Development in Young Adults (Cardia) Study - Coordinating Center (Cc)University of Alabama at Birmingham · 75N92023F00001$8,593,231Jun 30, 2027in 7 monthsAL
The Goal of This Task Order Is to Provide Technical Support in Accordance With the Statement of Work (Sow) to the Division of Cancer Epidemiology and Genetics Metabolic Epidemiology Branch…Westat, Inc. · 75N91024F00002$3,350,420Jun 30, 2027in 7 monthsMD
Coronary Artery Risk Development in Young Adults (Cardia) Study - Oakland Field CenterKaiser Foundation Hospitals · 75N92023F00001$2,955,023Jun 30, 2027in 7 monthsCA
Coronary Artery Risk Development in Young Adults (Cardia) Study - Birmingham Field CenterUniversity of Alabama at Birmingham · 75N92023F00001$2,937,323Jun 30, 2027in 7 monthsAL
To Develop a Therapeutic Small Molecule Viral Entry Inhibitor As a Medical Countermeasure for Filovirus Infection.Arisan Therapeutics Inc · 75N93026C00012$2,933,547Jun 30, 2027in 7 monthsCA
Coronary Artery Risk Development in Young Adults (Cardia) Study - Chicago Field CenterNorthwestern University · 75N92023F00001$2,667,728Jun 30, 2027in 7 monthsIL
Coronary Artery Risk Development in Young Adults (Cardia) Study - University of Minnesota Field Center.Regents of the University of Minnesota · 75N92023F00001$2,213,059Jun 30, 2027in 7 monthsMN
Characterization of a Non-Paralyzing Bont-Based Biopharmaceutical for the Treatment of Neuropathic PainLovelace Biomedical Research Institute · 75N95021F00001$1,633,884Jun 30, 2027in 7 monthsNM
Sustained Release of VRC07 From Capsule-Intravaginal Ring for Preventing Hiv TransmissionMucommune LLC · 75N93025C00021$306,183Jun 30, 2027in 7 monthsNC
Nichd: R&D: Biological Testing Facility-Regulatory, Data Analysis, Database, and Project Management: Non-SeverableSri International · 75N94025F00005$149,973Jul 1, 2027in 7 monthsCA
Purity Specifications, Storage, and Distribution for Medications Development ContractResearch Triangle Institute · 75N95022C00014$2,842,135Jul 8, 2027in 7 monthsNC
This Contract Will Support Component a of the Collaborative Influenza Vaccine Innovation Centers (Civics) Program to Design and Evaluate Innovative Influenza Vaccine Approaches, Based on Principles…Icahn School of Medicine at Mount Sinai · 75N93019C00051$110,865,640Jul 9, 2027in 7 monthsNY
Medication Discovery Using Rat Models of Relapse. Period of Performance: 7/10/2024-7/9/2025. N01DA-24-8949Virginia Commonwealth University · 75N95024C00020$3,014,207Jul 9, 2027in 7 monthsVA
The Purpose of This Task Order Is to Identify the Remaining Gaps in Off-Label Use in Children and to Design Clinical Research (Systematic Literature Reviews, Epidemiology Studies, Population Pk…Duke University · 75N94022F00002$5,759,708Jul 12, 2027in 7 monthsNC
Synthesis and Distribution of Drugs of Abuse and Related Compounds. July 15, 2026 - July 14, 2027. Task Order 75N98026F00001 (TO10). N01DA-22-8944. Dap-Ncap-00000154Research Triangle Institute · 75N98026F00001$1,960,606Jul 14, 2027in 7 monthsNC
Material and Data Receipt, Storage, Shipping, and InventoryAdvanced Bioscience Laboratories, Inc. · 75N93023F00002$259,754Jul 14, 2027in 7 monthsMD
High Throughput Genotyping and Dna Sequencing for Studying the Genetic Contributions to Human Health and Disease: Whole Genome Sequencing for Cozen (Nci)The Johns Hopkins University · 75N92025F00002$317,275Jul 16, 2027in 7 monthsMD
High Throughput Genotyping and Dna Sequencing for Studying the Genetic Contributions to Human Health and Disease: Whole Genome Sequencing for Beebe-Dimmer (Nci)The Johns Hopkins University · 75N92025F00001$262,500Jul 16, 2027in 7 monthsMD
Pathology Research for the National Institute of Environmental Health Sciences - aIntegrated Laboratory Systems, LLC · 75N96026C00001$3,400,000Jul 17, 2027in 8 monthsNC
Pathology Research for the National Institute of Environmental Health Sciences-BExperimental Pathology Laboratories, Inc. · 75N96026C00002$1,600,000Jul 17, 2027in 8 monthsNC
Non-Clinical Studies in Support of Ind/Nda/Bla SubmissionsSri International · 75N93022F00001$6,179,640Jul 20, 2027in 8 monthsCA
Non-Clinical Studies in Support of Ind/Nda/Bla SubmissionsSri International · 75N93025F00001$5,133,730Jul 20, 2027in 8 monthsCA
Niddk: the Mission of the National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (Niddk) Is to Conduct and Support Biomedical Research, Research…Frontage Laboratories, Inc · 75N98026P01019$222,500Jul 20, 2027in 8 monthsPA
Subpopulations and Intermediate Outcomes in Copd (Spiromics) III - Task Area a - Year 3Regents of the University of California, San Francisco, the · 75N98026F00001$7,459,039Jul 24, 2027in 8 monthsCA
Subpopulations and Intermediate Outcomes in Copd (Spiromics) IIIRegents of the University of California, San Francisco, the · 75N92025F00003$7,037,497Jul 24, 2027in 8 monthsCA
Ind-Directed Development of Antiviral Therapies to Combat Diseases of Pandemic PotentialLeidos Biomedical Research Inc · 75N91022F00010$16,869,382Jul 26, 2027in 8 monthsMD
This Contract Will Support Component a of the Collaborative Influenza Vaccine Innovation Centers (Civics) Program to Design and Evaluate Innovative Influenza Vaccine Approaches, Based on Principles…Duke University · 75N93019C00050$67,973,443Jul 28, 2027in 8 monthsNC
Task Order 1A: Project Kick-Off Meeting and Task Order 2A: Ctsu Core Support Services & the Ctsu Enterprise of Systems; Cancer Trials Support Unit (Ctsu) IdiqWestat, Inc. · 75N91022F00001$97,248,696Jul 31, 2027in 8 monthsMD
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (Impac-Tb)Seattle Children's Hospital · 75N93021C00029$48,066,661Jul 31, 2027in 8 monthsWA
Development of Epetraborole As a Novel Therapeutic for Melioidosis and Additional Antimicrobial Resistant (Amr) Bacterial Biothreat Pathogens.AN2 Therapeutics, Inc · 75N93022C00059$9,235,577Jul 31, 2027in 8 monthsCA
Task Order 4A Site Study Setup: Cancer Trials Support Unit (Ctsu) IdiqWestat, Inc. · 75N91022F00002$7,552,799Jul 31, 2027in 8 monthsMD
Rational Systemic Characterization and Selection of Adjuvants for Hiv Vaccine Candidates (R-Casa)Scripps Research Institute · 75N93024C00053$5,802,669Jul 31, 2027in 8 monthsCA
Task Order 1A - Project Kickoff Meeting and Task Order 3A - Awareness, Education, and Training; Contract Title: Cancer Trials Support Unit (Ctsu)Edj Associates, Inc. · 75N91022F00001$5,226,632Jul 31, 2027in 8 monthsVA
Task Order 1A -Project Kickoff Meeting and Task Order 5A: Centralized Protocol Writing Support; Contract Title: Cancer Trials Support Unit Ctsu.Technical Resources International, Inc. · 75N91022F00001$3,972,999Jul 31, 2027in 8 monthsMD
Scalable, Reliable Artificial Intelligence (Ai)/Machine Learning (Ml)- Driven Integration and Interrogation to Modernize the Step Pediatric Excipient DatabaseAdvanced Bioscience Laboratories, Inc. · 75N93026F00001$2,674,036Jul 31, 2027in 8 monthsMD
Finalization, Procurement of Regulatory Approval, and Complete Start-Up Activities for the Ovaprene Vaginal Device Clinical TrialHealth Decisions, Inc. · 75N94023F00003$2,187,390Jul 31, 2027in 8 monthsNC
Award Task 4: High Throughput ScreeningSri International · 75N94024F00001$713,993Jul 31, 2027in 8 monthsCA
Evaluating HBVZ10-Based Therapied for Cccdna Clearance: Virological Foundation and Synergistic CombinationsHbvtech, L.l.c · 75N93025C00023$606,178Jul 31, 2027in 8 monthsMD
B-Smart - Broadly Neutralizing Antibodies for Sarna Mediated Antiviral Response TherapyLynntech Inc. · 75N93025C00022$599,989Jul 31, 2027in 8 monthsTX
Therapeutic Vaccine Platform to Boost Immune Responses in TuberculosisL2 Diagnostics LLC · 75N93025C00024$599,471Jul 31, 2027in 8 monthsCT
EO14398. Radiological and Nuclear Countermeasures Program (Rncp). August 1, 2026 - July 31, 2027. Dap-Ncap-00000102University of Maryland, Baltimore · 75N98026C00051$551,842Jul 31, 2027in 8 monthsMD
Nichd: R&D: Span Analysis 2025: Non-SeverableRegents of the University of Minnesota · 75N94025F00001$366,724Jul 31, 2027in 8 monthsMN
Nichd: R&D: Androgenic, Anabolic, and Preclinical Safety Studies: Non-SeverableSri International · 75N94025F00006$323,949Jul 31, 2027in 8 monthsCA
Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders.Research Triangle Institute · 75N95024C00021$1,852,395Aug 3, 2027in 8 monthsNC
The Government Requires Professional Services to Support NIH/Nhgri/Gards Researchers in Community Engagement, Patient Enrollment, Biospecimen Collection, and Demographic Data Collection for Genetic…Inbiomedic Sac · 75N98026P00981$249,177Aug 4, 2027in 8 monthsMD
Data Coordinating Center to Provide Services to Work Collaboratively With the National Neurohiv Tissue Consortium Clinical Sites to Provide Management and Database Capabilities, Scientific…The Emmes Company, LLC · 75N95023C00013$13,535,405Aug 6, 2027in 8 monthsMD
The Purpose of This Task Order Is to Fund the Guaranteed Minimum Amount of the Contract.Technical Resources International, Inc. · 75N93022F00001$1,058,632Aug 7, 2027in 8 monthsMD
Copd Gene - Genetic Epidemiology of Copd - Task Area a: Year 3 - August 10, 2025 - August 9, 2026National Jewish Health · 75N92025F00001$9,292,344Aug 9, 2027in 8 monthsCO
Copd Gene - Genetic Epidemiology of Copd - Task Area a: Year 4 - August 10, 2026 - August 09, 2027National Jewish Health · 75N98026F00001$9,292,283Aug 9, 2027in 8 monthsCO
Copd(Gene): Task B: "stewardship of Biospecimen and Data Repositories"National Jewish Health · 75N92023F00002$3,691,520Aug 9, 2027in 8 monthsCO
Conduct Confirmatory and Specialized in Vitro Testing and Screening of Interventional Agents in Standard FormatsResearch Triangle Institute · 75N93023F00001$334,662Aug 15, 2027in 8 monthsNC
Seer*educate Base AwardFred Hutchinson Cancer Center · 75N91024F00001$1,399,684Aug 16, 2027in 8 monthsWA
New Task Order Alcohol Cue Human Laboratory Study Testing Apremilast. Contractor to Serve As a Clinical Research Site for a Multiple-Site Clinical Trial to Test Apremilast for the Treatment of…Rector & Visitors of the University of Virginia · 75N94025F00002$682,868Aug 17, 2027in 9 monthsVA
Clinical Trial Materials for Virus Vaccines. Cgmp Preparation of Live Denv-4 Clinical Lot. Task Order 14.Charles River Laboratories, Inc. · 75N98026F00003$371,635Aug 18, 2027in 9 monthsMA
Midrc Sustainment of Operations and Maintenance and Inter-Operability FY27The University of Chicago · 75N98026F00001$2,121,302Aug 19, 2027in 9 monthsMD
Niaaa: Service: Task Order 03 Award for Kor Antagonist Anticaprant Study: Non-SeverableThe Medical University of South Carolina · 75N94026F00001$272,990Aug 19, 2027in 9 monthsSC
The Sister Study: Task Order 001 - Core ActivitiesSocial & Scientific Systems, Inc. · 75N96018F00001$61,994,334Aug 22, 2027in 9 monthsNC
The Nntc Collects, Store, and Provide Clinical Data and Well Characterized Biological Specimens, Including Post-Mortem Tissue From Study Volunteers and/or Organ Donors With Hiv As Well As…Icahn School of Medicine at Mount Sinai · 75N95023C00015$12,490,041Aug 22, 2027in 9 monthsNY
The Nntc Collects, Store, and Provide Clinical Data and Well Characterized Biological Specimens, Including Post-Mortem Tissue From Study Volunteers and/or Organ Donors With Hiv As Well As…University of California San Diego · 75N95023C00014$11,090,349Aug 22, 2027in 9 monthsCA
The Nntc Collects, Store, and Provide Clinical Data and Well Characterized Biological Specimens, Including Post-Mortem Tissue From Study Volunteers and/or Organ Donors With Hiv As Well As…University of California, Los Angeles · 75N95023C00017$2,872,546Aug 22, 2027in 9 monthsMD
The Nntc Collects, Store, and Provide Clinical Data and Well Characterized Biological Specimens, Including Post-Mortem Tissue From Study Volunteers and/or Organ Donors With Hiv As Well As…University of Texas Medical Branch at Galveston · 75N95023C00016$2,527,425Aug 22, 2027in 9 monthsMD
Task Order 4: Support Services for the Prevention and Treatment Through a Comprehensive Care Continuum for Hiv-Affected Adolescents in Resource Constrained Settings Implementation Science NetworkWestat, Inc. · 75N94023F00004$4,735,686Aug 24, 2027in 9 monthsMD
FY23. to 11 - Ctn-0145: Standard Versus High Dose Ed-Initiated Buprenorphine Induction. Pop: 8/28/23 - 8/27/24.The Emmes Company, LLC · 75N95023F00004$1,036,687Aug 27, 2027in 9 monthsMD
To Award the Base Period for Nimh Psychoactive Drug Screening Program (Pdsp). Base Pop: 08/30/2023-08/29/2024.University of North Carolina at Chapel Hill · 75N95023C00021$11,726,648Aug 29, 2027in 9 monthsNC
Nci Operational Task Order, FY26-FY27Leidos Biomedical Research Inc · 75N91025F00016$825,985,691Aug 30, 2027in 9 monthsMD
Niaid Vrc FY26-27 Operational Task OrderLeidos Biomedical Research Inc · 75N91025F00014$87,806,507Aug 30, 2027in 9 monthsMD
Cptac Biospecimen CollectionLeidos Biomedical Research Inc · 75N91020F00030$37,727,154Aug 30, 2027in 9 monthsMD
The Niaid Dir FY26-27 Operational Task OrderLeidos Biomedical Research Inc · 75N91025F00013$17,766,274Aug 30, 2027in 9 monthsMD
Clinical, Genetic, and Epidemiological Support Services Task OrderWestat, Inc. · 75N91023F00004$10,275,683Aug 31, 2027in 9 monthsMD
EO14398 Evaluation and Conduct of Computational and Alternative Toxicological Research for the National Institute of Environmental Health Sciences. Contractor Conducts and Evaluates Toxicological…Sciome LLC · 75N94026C00002$5,463,757Aug 31, 2027in 9 monthsNC
FY25. Sbir Topic 167 Phase II: Ultraportable Lab-on-a-Chip Biosensor System for Rapid Postmortem Toxicology. Period of Performance: 9/01/25-8/31/27Portable Diagnostic Systems Inc · 75N95025C00008$2,000,000Aug 31, 2027in 9 monthsNJ
Phase 2: Recruitment and Follow-Up for the Study of Pregnancy and Neonatal Health (Span) (Aims 1 and 2)University of Utah · 75N94024F00001$1,961,467Aug 31, 2027in 9 monthsUT
Reb Epidemiology and Dosimetry Studies of Radiation Related CancersSocial & Scientific Systems, Inc. · 75N91023F00001$1,780,109Aug 31, 2027in 9 monthsMD
Clinical Trial Materials for Virus Vaccines. Historic H3N2 and H10N7 Influenza Challenge Viruses. Task Order 15.Charles River Laboratories, Inc. · 75N98026F00004$1,006,390Aug 31, 2027in 9 monthsMA
Multiplexed Nucleic Acid Self-Test for Reproducible and Sensitive Hiv DetectionVivid Bioinnovations, Pbc · 75N93025C00029$595,337Aug 31, 2027in 9 monthsCA
Receptor Profile Screening. N01DA-23-8937. Pop September 1, 2026 to August 31, 2027. Dap-Ncap-00000159Eurofins Discovery Services North America, LLC · 75N98026F00001$136,499Aug 31, 2027in 9 monthsMO
Niaid / Childrens National Medical Center Joint Clinical Research Program (Jcrp) Immunologic and Infectious Diseases Clinical ResearchLeidos Biomedical Research Inc · 75N91022F00021$10,001,104Sep 1, 2027in 9 monthsMD
High Throughput Genotyping and Dna Sequencing for Studying the Genetic Contributions to Human Health and Disease -Whole Exome Sequencing (Saliva); Whole Genome Sequencing Upgrade for Nci (Haiman)The Johns Hopkins University · 75N92024F00003$2,556,500Sep 1, 2027in 9 monthsMD
Nia: Supply: Light Sheet Microscope : N/aMicrobrightfield, LLC · 75N98026P01500$171,706Sep 1, 2027in 9 monthsVT
Hngr(310)Fc GMP3 Campaign and Octet Method DevelopmentLeidos Biomedical Research Inc · 75N91019F00140$9,222,324Sep 2, 2027in 9 monthsMD
Mpf/Camris Solutions, LLC:1497655 [24-002747]Mpf/Camris Solutions, LLC · 75N98024C00021$2,451,762Sep 2, 2027in 9 monthsMD
Direct to Phase II Sbir Concept Award for Novel Iontophoretic Drug Delivery Device for Local and Effective Treatment of Oral CancerContinuity Biosciences, LLC · 75N91025C00024$2,995,581Sep 4, 2027in 9 monthsNC
Sbir Topic: Development of Devices, Diagnostic Technologies, or Digital Health Tools for Treatment, Detection, and Diagnosis of Pediatric Cancers and/or Rare Cancers Phase I Concept Title…Columbus Nanoworks, Inc. · 75N91025C00045$506,498Sep 4, 2027in 9 monthsOH
Discovery and Development of Cancer Therapeutics for Next ProgramLeidos Biomedical Research Inc · 75N91022F00019$22,364,766Sep 8, 2027in 9 monthsMD
Niaid Dmid Influenza Vaccine Project (H5N1) - Influenza Variant Virus VaccinesLeidos Biomedical Research Inc · 75N91024F00032$7,985,002Sep 8, 2027in 9 monthsMD
High Throughput Genotyping and Dna Sequencing for Studying the Genetic Contributions to Human Health and Disease -Epic Methylation Array for Nci (Song)The Johns Hopkins University · 75N92024F00004$1,263,500Sep 8, 2027in 9 monthsMD
High Throughput Genotyping and Dna Sequencing for Studying the Genetic Contributions to Human Health and Disease - Epic Methylation Array & Gda Array for Nci (Francis)The Johns Hopkins University · 75N92024F00005$1,018,995Sep 8, 2027in 9 monthsMD
High Throughput Genotyping and Dna Sequencing for Studying the Genetic Contributions to Human Health and Disease - Whole Exome Sequencing for Nci (Soiffer)The Johns Hopkins University · 75N92024F00006$416,000Sep 8, 2027in 9 monthsMD
High Throughput Genotyping and Dna Sequencing for Studying the Genetic Contributions to Human Health and Disease -Whole Genome Sequencing (30X) for Nhgri (Quinlan)The Johns Hopkins University · 75N92024F00009$182,700Sep 8, 2027in 9 monthsMD
Component a of the Collaborative Influenza Vaccine Innovation Centers (Civics) Program to Design and Evaluate Innovative Influenza Vaccine Approaches, Based on Principles of Influenza Immunity, That…University of Georgia Research Foundation, Inc. · 75N93019C00052$76,786,980Sep 9, 2027in 9 monthsGA
Stable Clone Production for Anti-Ebv Monoclonal AntibodiesLeidos Biomedical Research Inc · 75N91023F00020$3,237,758Sep 10, 2027in 9 monthsMD
Ncats-Dpi-22-0101 - Creation of an Open-Source Process to Manufacture Aav Vector-Based Gene Therapy Candidates for Non-Commercial Clinical StudiesLeidos Biomedical Research Inc · 75N91022F00016$13,973,744Sep 11, 2027in 9 monthsMD
Arpa-H Sbir Topic 04- Ivd Device for Patient Immune Profiling and Personalized Treatment SelectionFeromics Inc · 75N91024C00036$4,091,483Sep 11, 2027in 9 monthsMA
Task Order 1 - Project Tracking and ConsultationRegents of the University of Minnesota · 75N94022F00001$110,412Sep 11, 2027in 9 monthsMN
Iitri - PA1 Task Order #07Iit Research Institute · 75N98026F00002$108,506Sep 11, 2027in 9 monthsIL
Virtual Research Support PilotLeidos Biomedical Research Inc · 75N91022F00023$8,703,603Sep 14, 2027in 9 monthsMD
Jackson Heart Study (Jhs) Field CenterUniversity of Mississippi Medical Center · 75N92025F00001$7,287,080Sep 14, 2027in 9 monthsMS
Jackson Heart Study (Jhs) Coordinating Center: Task Area a - Core Study OperationsWake Forest University Health Sciences · 75N92025F00001$7,241,581Sep 14, 2027in 9 monthsNC
Arpa-H Sbir Phase II Topic Arpa-H 04 Intra-Operative Contrast AgentsTrace Biosciences Inc · 75N91023C00042$4,218,974Sep 14, 2027in 9 monthsOR
Sbir Phase II - Enhanced Overall Survival in High-Risk Pediatric Solid Tumors Using a Novel Oral Small MoleculeNovomedix LLC · 75N91025C00051$2,977,013Sep 14, 2027in 9 monthsCA
Jhs Training and Education Center Nhlbi Funding 9/15/2025 - 9/14/2026Tougaloo College · 75N92025F00001$2,901,022Sep 14, 2027in 9 monthsMD
Jackson Heart Study (Jhs) Field Center: Task Area B.1. - Legacy Cohort Exam 5 PreparationUniversity of Mississippi Medical Center · 75N98026F00001$2,608,281Sep 14, 2027in 9 monthsMS
Jhs Training and Education Center Nhlbi FundingJackson State University · 75N92025F00001$2,566,335Sep 14, 2027in 9 monthsMD
Jackson Heart Study (Jhs) Training and Education Center RenewalThe University of Southern Mississippi · 75N92025F00001$2,528,529Sep 14, 2027in 9 monthsMS
Jackson Heart Study (Jhs) Community Engagement Center (Cec): Task Area aG.A. Carmichael Family Health Center, Inc · 75N92025F00001$1,857,448Sep 14, 2027in 9 monthsMS
Jackson Heart Study (Jhs) Coordinating Center: Task Area B.1. Legacy Cohort Exam 5 PreparationWake Forest University Health Sciences · 75N98026F00001$1,717,532Sep 14, 2027in 9 monthsNC
Hiv Assay Development and Testing to Identify Targeted Activator of Cell Kill MoleculesResearch Triangle Institute · 75N93024F00001$1,480,550Sep 14, 2027in 9 monthsNC
Management of Unhealthy Opioid and Polysubstance Use Among Patients in Primary Care Settings. FY22. Pop 9/15/22 - 9/14/27.The Emmes Company, LLC · 75N95022F00003$1,299,926Sep 14, 2027in 9 monthsMD
Phase I - Development of Therapeutic or Preventative Technologies for Treatment or Prevention of Pediatric Cancers and/or Rare Cancers Sbir Contractription.Nomocan Pharmaceuticals LLC · 75N91025C00050$499,166Sep 14, 2027in 9 monthsNY
Sbir FY25 Concept Award: Development of Engineered Trna Therapeutics for Clear Cell Renal Cell CarcinomaCloverleaf Bio, Inc. · 75N91025C00020$300,000Sep 14, 2027in 9 monthsCT
Sbir FY25 Concept Award: Targeting Dysfunctional Chromatin Networks in DipgTippingpoint Biosciences, Inc. · 75N91025C00021$300,000Sep 14, 2027in 9 monthsCA
Next Generation Dual Targeting Adcs for Sclc Empowered by Generative Ai.Marwell Bio Inc · 75N91025C00040$300,000Sep 14, 2027in 9 monthsCA
FY2025 Sbir Concept Clearance Award or Topic Development of Therapeutic or Preventative Technologies for Treatment or Prevention of Pediatric Cancers and/or Rare CancersAso Therapeutics, Inc. · 75N91025C00011$299,991Sep 14, 2027in 9 monthsCA
Seer Research Support Registries Program and Linkages and Data Management SupportTennessee Department of Health · 75N91024F00002$166,947Sep 14, 2027in 9 monthsTN

End dates are the current period of performance; options not yet exercised can extend them. An ending contract may be competed again, extended, or moved to another vehicle. BPA calls and orders shorter than six months are left out. Department of Defense contracts appear on USAspending.gov about 90 days after award.

Get new notices under NAICS 541715

New contract opportunities under NAICS 541715, research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy